title: [Transfusion strategy for patients in therapeutic aplasia. Experience of the Henri Mondor Hospital apropos of 2 successive protocols].
abstract: Retrospective analysis of two transfusion protocols applied in our institution to the bone marrow transplanted patients was conducted. Granulocyte transfusions should be only proposed as a therapeutic treatment to patients with severe well documented bacterial infection resistant to an adapted antibiotherapy. Leukocyte-depleted blood products reduce the incidence of HLA-immunization but do not influence the frequency of CMV infections. Random single donor platelet concentrates (obtained by cytapheresis) could decrease the incidence of polyspecific HLA-antibodies in comparison with the use of random standard platelet concentrates. The best transfusion protocol should associate leukocyte-depleted blood products with transfusion of prophylactic single donor platelet concentrates. In our institution, this protocol is less expensive than the protocol with prophylactic white blood cell transfusions and has the same cost than other protocols using standard blood products.
authors.affiliation: Centre de Transfusion, Hôpital Henri Mondor, Créteil.
authors.forename: P
authors.initials: P
authors.lastname: Bierling
authors.forename: B
authors.initials: B
authors.lastname: Lecollier
authors.forename: C
authors.initials: C
authors.lastname: Cordonnier
authors.forename: P
authors.initials: P
authors.lastname: Wallet
authors.forename: M
authors.initials: M
authors.lastname: Rodet
authors.forename: N
authors.initials: N
authors.lastname: Duedari
mesh_terms: D000380:Agranulocytosis / Q000628:therapy*; D001803:Blood Transfusion / Q000379:methods*; D001853:Bone Marrow / Q000276:immunology; D016026:Bone Marrow Transplantation; D003586:Cytomegalovirus Infections / Q000209:etiology; D005260:Female; D006098:Granulocytes / Q000637:transplantation; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D007114:Immunization; D017708:Leukocyte Transfusion; D008297:Male; D009503:Neutropenia / Q000209:etiology / Q000628:therapy*; D017713:Platelet Transfusion; D012189:Retrospective Studies; D013921:Thrombocytopenia / Q000209:etiology / Q000628:therapy*; D065227:Transfusion Reaction
chemical_list: D006680:HLA Antigens
vernacular_title: Stratégie transfusionnelle pour les malades en aplasie thérapeutique. Expérience de l'Hôpital Henri Mondor à propos de 2 protocoles successifs.